Novel evidence on hepatitis C virus-associated glomerular disease

Kidney International

Volumn 86, Issue 3, 2014, Pages 466-469

  Fabrizi, Fabrizio ^a,b   Messa, Piergiorgio ^a   Martin, Paul ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; HEPATITIS C ANTIBODY;

ANTIBODY DETECTION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HEMATURIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY BIOPSY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NONHUMAN; NOTE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; RNA ANALYSIS; ULTRACENTRIFUGATION; VIRUS DETECTION; BLOOD; FEMALE; GENETICS; GLOMERULONEPHRITIS; HEPACIVIRUS; IMMUNOLOGY; MALE; NEPHRITIS, HEREDITARY;

FEMALE; GLOMERULONEPHRITIS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; NEPHRITIS, HEREDITARY; RNA, VIRAL;

EID: 84907380954     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.181     Document Type: Note

References (19)

1. El-Serag H, Hampel H, Yeh C et al. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002; 36: 1439-1445.
2. Fabrizi F, Martin P, Dixit V et al. Hepatitis C virus infection and kidney disease: a meta-analysis. Clin J Am Soc Nephrol 2012; 7: 1-9.
3. Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008; 73: S1-S99.
4. Castillo I, Martinez-Ara J, Olea T et al. High prevalence of occult hepatitis C virus infection in patients with primary and secondary glomerular nephropathies. Kidney Int 2014; 86: 619-624.
5. Kamar N, Nicot F, Izopet J et al. Occult hepatitis C virus infection in hemodialysis patients: examining the evidence. Am J Kidney Dis 2009; 54: 10-12.
6. Abou-Zeid A, El-Sayegh H. Toll-like receptor 3 gene expression in Egyptian patients with glomerulonephritis and hepatitis C virus infection. Scand J Clin Lab Invest 2011; 71: 456-461.
7. Crook E, Penumalee S, Gavini B et al. Hepatitis C is a predictor of poorer renal survival in diabetic patients. Diabetes Care 2006; 28: 2187-2191.
8. Tsui J, Vittinghoff E, Anastos K et al. Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study. Am J Kidney Dis 2009; 54: 43-50.
9. Arase Y, Suzuki F, Kawamura Y et al. Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy. Hepatol Res 2011; 41: 946-954.
10. Satapathy S, Lingisetty C, Williams S. Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection. Hepatol Int 2012; 6: 369-378.
11. Noureddine L, Usman S, Yu Z et al. Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis. Am J Nephrol 2010; 32: 311-316.
12. Barril G, Castillo I, Arenas M et al. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol 2008; 19: 2288-2292.
13. Nicot F, Kamar N, Mariamè B et al. No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients. Transplant Int 2010; 23: 594-601.
14. De Marco L, Gillio-Tos A, Fiano V et al. Occult HCV infection: an unexpected finding in a population unselected for hepatis disease. PLoS One 2009; 4: e8128.
15. Zaghloul H, El-Sherbiny W. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells. Immunol Invest 2010; 39: 284-291.
16. Idrees M, Lal A, Malik F et al. Occult hepatitis C virus infection and associated predictive factors: the Pakistan experience. Infect Genet Evol 2011; 11: 442-445.
17. Bokharaei-Salim F, Keyvani H, Monavari S et al. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol 2011; 833: 989-995.
18. Farahani M, Bokharaei-Salim F, Ghane M et al. Prevalence of occult hepatitis C virus infection in Iranian patients with lymphoproliferative disorders. J Med Virol 2013; 86: 235-240.
19. Keyvani H, Bokharaei-Salim F, Monavari S et al. Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis. Hepatitis Monthly 2013; 13: e11290.